ID

33712

Description

Incretin-based Drugs and Acute Pancreatitis; ODM derived from: https://clinicaltrials.gov/show/NCT02476760

Lien

https://clinicaltrials.gov/show/NCT02476760

Mots-clés

Versions (1)
  1. 20/12/2018 20/12/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

20 décembre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes Mellitus, Type 2 NCT02476760

Anglais

Eligibility Diabetes Mellitus, Type 2 NCT02476760

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with a first-ever prescription for a non-insulin anti-diabetic drug, including biguanides, sulfonylureas, thiazolidinediones, dpp-4 inhibitors, glp-1 analogs, alpha-glucosidase inhibitors, meglitinides or combinations of these drugs from the earliest availability of data at each site to the last date of availability of data.
Description

Antidiabetics Except Insulin | Biguanides | Sulfonylureas | Thiazolidinediones | DPP-4 Inhibitor | GLP-1 Analogue | alpha-Glucosidase Inhibitors | Meglitinide | Combined Modality Therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C0332300
UMLS CUI [1,3]
C0021641
UMLS CUI [2]
C0005382
UMLS CUI [3]
C0038766
UMLS CUI [4]
C1257987
UMLS CUI [5]
C3537225
UMLS CUI [6]
C3273809
UMLS CUI [7]
C1299007
UMLS CUI [8]
C0065880
UMLS CUI [9]
C0009429
patients with at least 1 year of history in the database.
Description

Medical History Database Duration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0242356
UMLS CUI [1,3]
C0449238
patients at least 18 years of age.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who died or left the cohort before the year the first incretin-based drug entered the market.
Description

Patient Outcome - Died | Cohort Withdrawal by Subject

Type de données

boolean

Alias
UMLS CUI [1]
C1546956
UMLS CUI [2,1]
C0599755
UMLS CUI [2,2]
C1710677
patients who never added-on or switched to a new anti-diabetic drug after incretin-based drugs entered the market up until june 30, 2014.
Description

Absence Antidiabetics Additional | Absence Antidiabetics Change

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0935929
UMLS CUI [1,3]
C1524062
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0935929
UMLS CUI [2,3]
C0392747
patients with a previous diagnosis of pancreatic cancer, those who underwent pancreatectomy, those with diagnoses of congenital defects of the pancreas, cystic fibrosis, lupus, or previous bariatric surgery, at any time prior to study cohort entry.
Description

Pancreatic carcinoma | Pancreatectomy | Congenital defects Pancreas | Cystic Fibrosis | Lupus Erythematosus | Bariatric Surgery

Type de données

boolean

Alias
UMLS CUI [1]
C0235974
UMLS CUI [2]
C0030279
UMLS CUI [3,1]
C0000768
UMLS CUI [3,2]
C0030274
UMLS CUI [4]
C0010674
UMLS CUI [5]
C0409974
UMLS CUI [6]
C1456587
patients diagnosed with hiv or initiating haart therapy before and at study cohort entry.
Description

HIV Infection | HAART

Type de données

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0887947
patients hospitalized for acute pancreatitis in the 30 days before study cohort entry.
Description

Hospitalization Pancreatitis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C0030305
Retour au début de la page

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT02476760

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Antidiabetics Except Insulin | Biguanides | Sulfonylureas | Thiazolidinediones | DPP-4 Inhibitor | GLP-1 Analogue | alpha-Glucosidase Inhibitors | Meglitinide | Combined Modality Therapy
Item
patients with a first-ever prescription for a non-insulin anti-diabetic drug, including biguanides, sulfonylureas, thiazolidinediones, dpp-4 inhibitors, glp-1 analogs, alpha-glucosidase inhibitors, meglitinides or combinations of these drugs from the earliest availability of data at each site to the last date of availability of data.
boolean
C0935929 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C0021641 (UMLS CUI [1,3])
C0005382 (UMLS CUI [2])
C0038766 (UMLS CUI [3])
C1257987 (UMLS CUI [4])
C3537225 (UMLS CUI [5])
C3273809 (UMLS CUI [6])
C1299007 (UMLS CUI [7])
C0065880 (UMLS CUI [8])
C0009429 (UMLS CUI [9])
Medical History Database Duration
Item
patients with at least 1 year of history in the database.
boolean
C0262926 (UMLS CUI [1,1])
C0242356 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Age
Item
patients at least 18 years of age.
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Patient Outcome - Died | Cohort Withdrawal by Subject
Item
patients who died or left the cohort before the year the first incretin-based drug entered the market.
boolean
C1546956 (UMLS CUI [1])
C0599755 (UMLS CUI [2,1])
C1710677 (UMLS CUI [2,2])
Absence Antidiabetics Additional | Absence Antidiabetics Change
Item
patients who never added-on or switched to a new anti-diabetic drug after incretin-based drugs entered the market up until june 30, 2014.
boolean
C0332197 (UMLS CUI [1,1])
C0935929 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])
C0332197 (UMLS CUI [2,1])
C0935929 (UMLS CUI [2,2])
C0392747 (UMLS CUI [2,3])
Pancreatic carcinoma | Pancreatectomy | Congenital defects Pancreas | Cystic Fibrosis | Lupus Erythematosus | Bariatric Surgery
Item
patients with a previous diagnosis of pancreatic cancer, those who underwent pancreatectomy, those with diagnoses of congenital defects of the pancreas, cystic fibrosis, lupus, or previous bariatric surgery, at any time prior to study cohort entry.
boolean
C0235974 (UMLS CUI [1])
C0030279 (UMLS CUI [2])
C0000768 (UMLS CUI [3,1])
C0030274 (UMLS CUI [3,2])
C0010674 (UMLS CUI [4])
C0409974 (UMLS CUI [5])
C1456587 (UMLS CUI [6])
HIV Infection | HAART
Item
patients diagnosed with hiv or initiating haart therapy before and at study cohort entry.
boolean
C0019693 (UMLS CUI [1])
C0887947 (UMLS CUI [2])
Hospitalization Pancreatitis
Item
patients hospitalized for acute pancreatitis in the 30 days before study cohort entry.
boolean
C0019993 (UMLS CUI [1,1])
C0030305 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial